“[Budget Impact Analysis of Empagliflozin for the Treatment of Type 2 Diabetes in Italy]”. 2016. Farmeconomia. Health Economics and Therapeutic Pathways 17 (1): 19-27. https://doi.org/10.7175/fe.v17i1.1238.